ProBio

📍 ProBio is proud to join the New Jersey Pavilion at Biotechnology Innovation Organization 2026 in San Diego. We’re honored to represent New Jersey’s thriving life sciences ecosystem as we partner with pioneers advancing #biologics, #plasmid DNA, viral vectors, #mRNA-LNP, and cell & gene therapies. Let’s connect at the NJ Pavilion and explore how ProBio can accelerate your program’s #success, 📅 Schedule a meeting with the team: https://lnkd.in/eNqJpbii 🔗 #Follow us: https://hubs.la/Q04hCsj60 Connect with our team: Julia Su, Ph.D., Lingqi Kong, PhD, Suraj Kachgal, Ph.D. Moonkyeong Jennifer Ju #BIO2026 #BIOInternational #CDMO #Biologics #CellAndGeneTherapy #GeneTherapy #CellTherapy #BiotechPartnerships #SanDiego #discovery #cgt #gct

📍Most CGT programs don’t fail in the lab; they stall when moving toward clinical development. That’s exactly what the SaxoCell Conference 2026 is focused on: Moving ATMPs from lab to clinic. ProBio will be there to #connect with teams tackling your move from research into clinical and #manufacturing readiness If you’re working on an early stage #CGT asset, come by our booth to discuss: • IIT trials for early patient data and cost savings • Building an #IND-ready process, including #IIT trials for early patient data • Avoiding delays between #discovery and #GMP • Creating a scalable path to clinic Our BD, Dr. Sami Ullah, will be there to meet and discuss your program. 📅 Schedule a meeting with the team: https://lnkd.in/eNqJpbii 🔗 #Follow us: https://hubs.la/Q04hCsj60

When speed increases, weak bioprocesses fail first. 📍 At New Horizons in Biologics and Bioprocessing on May 28 in Copenhagen, ProBio will focus on how teams can build robustness early and avoid downstream risk. 🗓 Dr Liang Tian will present “Engineering Robust Bioprocesses for Bispecific Antibody Development” at 11:55 AM. This session will go beyond theory, with actionable insights you can apply immediately: • How to design high concentration formulations (~140 mg per mL) that are manufacturable from day one • How to anticipate and control UF and DF risks before they impact timelines • How to implement purification strategies that proactively manage aggregation The takeaway is practical: robust processes are engineered upfront to protect speed, cost, and scalability

📍 ProBio is proud to join the New Jersey Pavilion at Biotechnology Innovation Organization 2026 in San Diego. We’re honored to represent New Jersey’s thriving life sciences ecosystem as we partner with pioneers advancing #biologics, #plasmid DNA, viral vectors, #mRNA-LNP, and cell & gene therapies. Let’s connect at the NJ Pavilion and explore how ProBio can accelerate your program’s #success, 📅 Schedule a meeting with the team: https://lnkd.in/eNqJpbii 🔗 #Follow us: https://hubs.la/Q04hCsj60 Connect with our team: Julia Su, Ph.D., Lingqi Kong, PhD, Suraj Kachgal, Ph.D. Moonkyeong Jennifer Ju #BIO2026 #BIOInternational #CDMO #Biologics #CellAndGeneTherapy #GeneTherapy #CellTherapy #BiotechPartnerships #SanDiego #discovery #cgt #gct

What “better discovery” actually looks like in practice.. Better discovery is not about generating more antibodies. It is about identifying the right functional leads, early. For emerging and mid-sized biopharma teams, that determines whether a program progresses or stalls. At ProBio, we focus on: • Identifying functional leads in weeks • Reducing screening costs by more than 50 percent • Filtering out weak candidates before downstream investment This is driven by early functional screening and integrated platforms designed around outcomes, not processes. That’s why ProBio is excited to present: “Innovative Platforms to Accelerate the Discovery of Functional Therapeutic Antibody Leads” 🗓 28 May | 13:50 (CEST) 📍 Antibody Engineering & Therapeutics Europe In this session, Dr Yu Liang will show how the ProSpeed™ platform enables teams to: • Rapidly identify high-quality functional leads • Gain early insight into developability • Reduce attrition by filtering earlier • Move faster into development If you cant make the meeting but you are still interested in learning more about next-generation strategies in early antibody discovery? Join our live webinar on June 3 with Dr. Derek Chen for additional platform insights and case studies. 👉 Register here: https://hubs.la/Q04hS6gv0

Discovery isn’t slowing down. Workflows are. When binding, validation, and confirmation happen separately, functional insight comes too late.  In this issue of ProBio Insights, we explore how integrated, function-first strategies are accelerating the path from binder to candidate. 👇 Read the full article to learn more  🗓️ Join our webinar on June 3: https://lnkd.in/eztTjJm2 

On the International Day for Biological Diversity, we’re reminded that nature is not only a source of inspiration, but a responsibility. As advanced therapies continue to evolve, the role of drug developers and CDMOs goes beyond innovation. It’s about ensuring that we harness biological systems responsibly, with a commitment to quality, sustainability, and ethical development. We’re proud to support partners in translating complex biology into life-changing therapies, while upholding the standards that protect both patients and the ecosystems that underpin scientific progress. Innovation and responsibility must go hand in hand. #BiodiversityDay #Biotech #CDMO #AdvancedTherapies #Sustainability #LifeSciences

📍ProBio Networking Update: Biopharma Momentum in Maryland Thank you to everyone who joined the Maryland Biopharma Networking Group May event at RAK Brewing Co. in Frederick, Maryland. 🙌 ProBio was proud to sponsor an evening that brought together BioPharma professionals for strong regional #networking, meaningful scientific exchange, and new conversations around development and #manufacturing support. 🤝 A special thank you to Joseph Kim, PhD, Senior Business Development Manager at ProBio, and Yu Liang, Vice President of Discovery, for representing ProBio and connecting with attendees throughout the event. As a global #CDMO, ProBio supports innovators across #Antibody Discovery, #biologics, viral vectors, #mRNA vaccines, #plasmids, and #protein therapeutics. 🔗 Contact our team: https://hubs.la/Q04hx-kK0 ➕ Follow ProBio: https://hubs.la/Q04hy8cM0 #BiotechEvents #CDMO #Discovery #AAV #LVV

Functional lead discovery remains a key bottleneck in biologics development. Too often, discovery still prioritizes binding over function. In this issue of ProBio Insights, we explore why—and what needs to change. 👇 Read the full article to learn more 🗓️ Join our webinar on June 3: https://lnkd.in/eztTjJm2

What to expect at this year’s Antibody Engineering Europe 2026? This year’s topics center around accelerating discovery to optimizing developability and antibody engineering is evolving fast. 📍 Antibody Engineering Europe 2026 🗓 27–29 May | Basel, Switzerland This event brings together leaders across discovery, engineering, and CMC to share practical strategies that shorten timelines, reduce risk, and improve clinical success rates. If you're working in biologics, it’s a must-attend to: ✔️ Explore the latest advances in antibody design, optimization, and developability ✔️ Gain insight into integrated approaches that connect discovery with downstream success ✔️ Network with peers tackling the same speed vs. quality challenge At ProBio, we’re excited to be part of the conversation. We’ll be showcasing how our ProSpeed® and ProBox™ platforms are helping teams: 🔹 Move faster from sequence to candidate selection 🔹 De-risk early development with integrated CMC insights 🔹 Build a smoother path from discovery through to IND If you’re looking to compress timelines without compromising quality, come and see how these technologies can support your next program. 👉 Join us in Basel and discover what faster, smarter antibody development can look like. #AntibodyEngineering #Biologics #DrugDevelopment #CMC #AntibodyTherapeutics #CDMO #ProBio